key: cord-0688706-3jzs5l0z authors: Mayanskiy, Nikolay; Brzhozovskaya, Ekaterina; Fedorova, Natalia; Lebedin, Yuri title: Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort date: 2021-06-03 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.05.082 sha: 23f0020ec53525dcb1757d3cf322d57419d3f831 doc_id: 688706 cord_uid: 3jzs5l0z Objectives Reverse-transcription PCR (RT-PCR) is considered the most sensitive method in detecting severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). However, this method is relatively resource- and time-consuming. Here, we compared SARS-CoV-2 nucleocapsid antigen (N-Ag) testing using an enzyme-linked immunosorbent assay (ELISA) with SARS-CoV-2 RNA detection. Methods Parallel SARS-CoV-2 RT-PCR and quantitative N-Ag ELISA analysis was executed in nasopharyngeal specimens obtained during SARS-CoV-2 screening in a cohort of pre-hospitalization patients. Results In total, 277 specimens were examined, including 182 (65.7%) RT-PCR-positive specimens, which demonstrated a median cycle threshold (Ct) value of 27 (interquartile range [IQR], 23-35). The SARS-CoV-2 N-Ag was detected in 164/182 RT-PCR-positive specimens (overall sensitivity, 90.1%). Among 95 RT-PCR-negative specimens, 72 were N-Ag-negative (specificity, 75.8%). SARS-CoV-2 RT-PCR and N-Ag ELISA results demonstrated a strong agreement (Cramer's V, 0.668; p < 0.001). N-Ag concentrations spanned from 5.4 to 296,000 pg/mL (median, 901 pg/mL; IQR, 43-1407 pg/mL) and were inversely correlated with Ct values (Spearman's r=-0.720; p < 0.001). Conclusions SARS-CoV-2 N-Ag ELISA results were in close agreement with RT-PCR results, and N-Ag concentrations were proportional to viral loads. Thus, SARS-CoV-2 quantitative antigen testing could be an additional diagnostic instrument for SARS-CoV-2. The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) poses serious challenges for the healthcare. Unprecedented demands in molecular testing have revealed a number of practical limitations of the PCR-based COVID-19 diagnostics. In this situation, additional, less demanding laboratory tools for SARS-CoV-2 detection, such as testing for viral antigens, merit consideration. A series of studies have reported the performance of numerous qualitative immunochromatographic rapid diagnostic tests [Young et al., 2020; Chaimayo et al.,2020; Lanser et al.,2020] , as well as several variants of automated quantitative assays [Hirotsu et al.,2021; Pollock et al.,2021] . In the present study, we performed quantitative SARS-CoV-2 nucleocapsid antigen (N-Ag) testing using an enzyme-linked immunosorbent assay (ELISA) in parallel with J o u r n a l P r e -p r o o f SARS-CoV-2 RNA detection in a series of nasopharyngeal specimens obtained during COVID-19 screening. Nasopharyngeal specimens (n=277) were obtained from individuals during routine screening for COVID-19 before planned hospitalization using the E-Transwab system (MWE, Great Britain) in October-November, 2020. RT-PCR was performed using the SARS-CoV-2/SARS-CoV Multiplex Specimens with a concentration of <5 pg/mL were considered negative. A subset of specimens demonstrating an N-Ag concentration >1000 pg/mL was diluted 10-1000-fold to obtain a true concentration value. Among 277 examined specimens, 182 (65.7%) were RT-PCR-positive (Table 1) J o u r n a l P r e -p r o o f At Ct≤20, there were no discordant results between the SARS-CoV-2 RT-PCR and N-Ag test (100% sensitivity) ( Table 1) ; >90% of specimens demonstrating a Ct value in the range of 21-30 were also positive in the N-Ag ELISA assay. Higher Ct values resulted in a decreased sensitivity rate of 85.3% and 50% for the Ct range of 31-35 and >35, respectively. In 82 (50%) RT-PCR-positive/N-Ag-positive specimens, an N-Ag concentration was above the upper detection limit of 1000 pg/mL of the ELISA assay (Fig. 1A) , therefore a repeated N-Ag measurement was performed in a subset of specimens from this cohort (n=32) after dilution (Fig. 1B) . Thus, the true N-Ag concentration was detected in 114 RT-PCR-positive specimens, which spanned from 5.4 to 296,000 pg/mL (median, 901 pg/mL; IQR, 43-1407 pg/mL). N-Ag concentrations correlated inversely with Ct values (Spearman's r=-0.720; p<0.001) suggesting a tight correlation with the viral load. Among 18 RT-PCR-negative specimens, where the N-Ag was detected, N-Ag concentrations fluctuated between 5.3 and 364 pg/mL (median, 11 pg/mL; IQR, 6-25 pg/mL). Our study demonstrated a strong agreement between SARS-CoV-2 RT-PCR and N-Ag testing results. The highest rate of concordant results was observed at Ct≤35 indicating that N-Ag test was highly likely to be positive in individuals with a significant viral load, who are considered as key vectors for virus spreading (Bullard et al.,2020) . In specimens with Ct>35, we observed much more discordant results with a negative N-Ag test. Several studies have demonstrated a direct correlation between viral load and SARS-CoV-2 culture positivity. According to Singanayagam et al. (2020) , probability of culturing virus was as low as 8.3% in samples with Ct>35, whereas Bullard et al. (2020) have not observed SARS-CoV-2 infectivity at Ct ≥24. Importantly, comparing to RT-PCR, antigen testing could be a better predictor for the presence of cultivable SARS-CoV-2 (Pekosz et al.,2021) . Ct values are widely used as a semiquantitative indicator of the SARS-CoV-2 viral J o u r n a l P r e -p r o o f load (Singanayagam et al.,2020) , thus, close relationship between SARS-CoV-2 antigen concentrations and RT-PCR Ct values, observed in the present study and by other authors (Pollock et al.,2021) may explain this finding. Thus, the epidemiological significance of specimens demonstrating high RT-PCR Ct values but no detectable SARS-CoV-2 antigen is not clear. N-Ag ELISA concentrations in RT-PCR-positive specimens were distributed over a wide range (at least 5 orders of magnitude), which was similar to findings by Hirotsu et al. (2021) . The quantitative SARS-CoV-2 antigen measurement may be instrumental for monitoring of viral clearance demonstrating a gradual decline over a broad concentration diapason in contrast to abrupt fluctuations in RT-PCR positivity (Hirotsu et al.,2021) . We observed a number of RT-PCR-negative specimens, where N-Ag was detected, albeit at low concentrations. Such results were unlikely to be related to the ELISA assay specificity, because it had been tested over a panel of coronavirus strains and no cross-reactivity was detected (CoviNAg instruction manual). The RT-PCR method as a relatively "fastidious" technique could be more demanding in terms of specimen quality and RNA stability comparing to antigen testing. Clinical as well as SARS-CoV-2 serology data could be helpful in resolving this situation, but this information was not available for the study. In conclusion, quantitative SARS-CoV-2 N-Ag ELISA demonstrating a comparable sensitivity with RT-PCR at the epidemiologically important Ct values may be a useful additional instrument for detecting SARS-CoV-2. Predicting infectious SARS-CoV-2 from diagnostic samples Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand CoviNAg instruction manual Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture Correlation of SARS-CoVquantitative antigen assay SARS-CoV-2/SARS-CoV instruction manual Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19 Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS antigen point-of-care test Figure 1. The nucleocapsid antigen (N-Ag) SARS-CoV-2 concentration distribution in relation to SARS-CoV-2 RT-PCR cycle threshold (Ct) values 5-1000 pg/mL); all specimens with a concentration of >1000 pg/mL and <5 pg/mL were depicted on the scattergram at 1000 pg/mL and 1 pg/mL, respectively. Dashed line at 5 pg/mL indicates the N-Ag positivity threshold. (B) To obtain the N-Ag true concentration, in a subset of specimens with an N-Ag concentration >1000 pg/mL (n=32) the measurement was The RNA extraction and RT-PCR were performed using the equipment of Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russia (grant 075-15-2019-1789). Note. Sensitivity and specificity of the N-Ag test were calculated considering RT-PCR results as the reference. Ct, cycle threshold; CI, confidential interval; NA, not applicable.